DAA2451 |
serine (or cysteine) proteinase inhibitor; clade A (alpha-1 antiproteinase; antitrypsin); member 12 increases with age |
Molecular |
mesenchymal stem cell |
Human |
SERPINA12 |
52.7% Increase DNA Methylation |
|
DAA2452 |
homeo box B1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
HOXB1 |
49.3% Decrease DNA Methylation |
|
DAA2453 |
hypothetical protein LOC126353 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MISP |
24.8% Decrease DNA Methylation |
|
DAA2454 |
chemokine (C-C motif) receptor 1 increases with age |
Molecular |
mesenchymal stem cell |
Human |
CCR1 |
31.2% Increase DNA Methylation |
|
DAA2455 |
CD34 antigen isoform b decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CD34 |
17.3% Decrease DNA Methylation |
|
DAA2456 |
PDZ and LIM domain 2 isoform 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PDLIM2 |
43.9% Increase DNA Methylation |
|
DAA2457 |
tumor necrosis factor receptor superfamily; member 17 increases with age |
Molecular |
mesenchymal stem cell |
Human |
TNFRSF17 |
18.8% Increase DNA Methylation |
|
DAA2458 |
hypothetical protein LOC146433 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
IL34 |
27.7% Decrease DNA Methylation |
|
DAA2459 |
transmembrane 4 superfamily member 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
TSPAN8 |
36.4% Increase DNA Methylation |
|
DAA2460 |
gelsolin-like capping protein decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CAPG |
19.3% Decrease DNA Methylation |
|
DAA2461 |
calcyphosine isoform b decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CAPS |
17.3% Decrease DNA Methylation |
|
DAA2462 |
Level of miR-519d decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR519D |
44.7% Decrease miRNA Level |
|
DAA2463 |
Level of miR-19a decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR19A |
40.7% Decrease miRNA Level |
|
DAA673 |
telomere length in hematopoietic stem cells |
Molecular |
hematopoietic stem cells |
Human |
— |
— |
|
DAA675 |
Beta-galactosidase expression increases in mesenchymal stem cells |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA676 |
Proliferation rate of mesenchymal stem cells is reduced |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA677 |
Proportion of apoptotic cells may be increased |
Physiological |
mesenchymal stem cell |
Human |
TP53 |
— |
|
DAA678 |
Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA932 |
Renewal capacity declines |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA934 |
Number of mature B cells leaving the bone marrow declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
DAA935 |
Pro-B cell generation and differentiation declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
DAA936 |
Volume of hematopoietic bone marrow decreases |
Physiological |
bone marrow |
Human |
— |
— |
|